Phibro Animal Health PAHC
NASDAQ PAHC
$38.80 -1.01 (-2.54%)
At close: Oct 23, 2026 · 4:00 PM EDT

Phibro Animal Health (PAHC) Cash & Current Investments (2013 - 2026)

Updated

Phibro Animal Health (PAHC) recorded Cash & Current Investments of $81.99 million in fiscal Q4 2026 (quarter ended Jun 30, 2026), up 6.4% from $77.04 million a year earlier and up 5.9% from the prior quarter.

Analysis

Phibro Animal Health (PAHC) Cash & Current Investments (2013 - 2026) Analysis & Trends

Starting with fiscal Q3 2013, Phibro Animal Health's Cash & Current Investments history includes 54 quarters.

  • Annual Cash & Current Investments has a five-year compound annual growth rate of -2.2% (FY2021 to FY2026).
  • Across earlier fiscal years, Cash & Current Investments came in at $77.04 million in FY2025 (-31.1%), $111.89 million in FY2024 (+41.7%), $78.98 million in FY2023 (-10.7%) and $88.46 million in FY2022 (-3.4%).
  • Quarterly Cash & Current Investments has ranged from $67.07 million in fiscal Q2 2025 to $111.89 million in fiscal Q4 2024 over the past five years.
  • On a year-over-year basis, Cash & Current Investments has increased for three consecutive quarters, with an average decline of 8.3% over the last eight quarters.
  • Peak year-over-year performance for Cash & Current Investments in the last five years was growth of 41.7% in fiscal Q4 2024, against a decline of 31.1% in fiscal Q4 2025 at the low end.
  • Per Business Quant, the preceding three fiscal quarters came in at $77.45 million (Q3 2026), $74.51 million (Q2 2026) and $85.27 million (Q1 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 17.23 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn 6.57 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 7.69 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn 4.90 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 3.18 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 11.70 Bn
10 Phibro Animal Health 1.57 Bn 1.25 Bn 134.40 Mn 81.99 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 81.99 Mn
Mar 31, 2026 77.45 Mn
Dec 31, 2025 74.51 Mn
Sep 30, 2025 85.27 Mn
Jun 30, 2025 77.04 Mn
Mar 31, 2025 70.35 Mn
Dec 31, 2024 67.07 Mn
Sep 30, 2024 89.84 Mn
Jun 30, 2024 111.89 Mn
Mar 31, 2024 98.75 Mn
Dec 31, 2023 92.49 Mn
Sep 30, 2023 91.15 Mn
Jun 30, 2023 78.98 Mn
Mar 31, 2023 77.24 Mn
Dec 31, 2022 78.42 Mn
Sep 30, 2022 86.28 Mn
Jun 30, 2022 88.46 Mn
Mar 31, 2022 92.85 Mn
Dec 31, 2021 95.49 Mn
Sep 30, 2021 97.18 Mn
API Access

Phibro Animal Health Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=PAHC&period=max&api_key=YOUR_API_KEY